GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Cyclically Adjusted PB Ratio

Kaken Pharmaceutical Co (TSE:4521) Cyclically Adjusted PB Ratio : 1.10 (As of May. 24, 2025)


View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2025-05-24), Kaken Pharmaceutical Co's current share price is 円3738.00. Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was 円3,395.12. Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.10.

The historical rank and industry rank for Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4521' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.06   Med: 1.91   Max: 3.82
Current: 1.11

During the past years, Kaken Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 3.82. The lowest was 1.06. And the median was 1.91.

TSE:4521's Cyclically Adjusted PB Ratio is ranked better than
69.38% of 663 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs TSE:4521: 1.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kaken Pharmaceutical Co's adjusted book value per share data for the three months ended in Dec. 2024 was 円4,099.329. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円3,395.12 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.87 1.51 1.29 1.10 -

Kaken Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 - 1.16 1.33 -

Competitive Comparison of Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


;
;

Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3738.00/3395.12
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Kaken Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=4099.329/110.7000*110.7000
=4,099.329

Current CPI (Dec. 2024) = 110.7000.

Kaken Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201503 1,861.057 97.900 2,104.382
201506 1,952.060 98.400 2,196.068
201509 2,065.899 98.500 2,321.777
201512 2,224.226 98.100 2,509.906
201603 2,170.555 97.900 2,454.346
201606 2,174.854 98.100 2,454.193
201609 2,287.978 98.000 2,584.481
201612 2,387.383 98.400 2,685.806
201703 2,511.659 98.100 2,834.257
201706 2,564.267 98.500 2,881.872
201709 2,688.549 98.800 3,012.372
201712 2,767.907 99.400 3,082.568
201803 2,824.301 99.200 3,151.715
201806 2,820.935 99.200 3,147.959
201809 2,950.200 99.900 3,269.141
201812 2,977.265 99.700 3,305.750
201903 3,049.751 99.700 3,386.233
201906 3,067.348 99.800 3,402.359
201909 3,165.142 100.100 3,500.312
201912 3,251.810 100.500 3,581.844
202003 3,301.051 100.300 3,643.333
202006 3,340.349 99.900 3,701.468
202009 3,416.998 99.900 3,786.403
202012 3,444.297 99.300 3,839.715
202103 3,555.927 99.900 3,940.352
202106 3,561.814 99.500 3,962.742
202109 3,657.685 100.100 4,045.012
202112 3,678.389 100.100 4,067.909
202203 3,642.313 101.100 3,988.171
202206 3,642.986 101.800 3,961.479
202209 3,730.820 103.100 4,005.837
202212 3,739.332 104.100 3,976.408
202303 3,636.138 104.400 3,855.560
202306 3,662.717 105.200 3,854.209
202309 3,755.451 106.200 3,914.580
202312 3,700.422 106.800 3,835.550
202403 3,796.013 107.200 3,919.950
202406 0.000 108.200 0.000
202409 4,076.781 108.900 4,144.166
202412 4,099.329 110.700 4,099.329

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kaken Pharmaceutical Co  (TSE:4521) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kaken Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co Headlines

No Headlines